Quantum Genomics SA
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
Quantum Genomics SA (ALQGC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -4.706x
Based on the latest financial reports, Quantum Genomics SA (ALQGC) has a cash flow conversion efficiency ratio of -4.706x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-7.64 Million) by net assets (€1.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Quantum Genomics SA - Cash Flow Conversion Efficiency Trend (2012–2022)
This chart illustrates how Quantum Genomics SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Quantum Genomics SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Quantum Genomics SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NeoTerrex Minerals Inc.
V:NTX
|
N/A |
|
Dave Inc. Warrants
NASDAQ:DAVEW
|
0.286x |
|
Ikapharmindo Putramas Tbk.
JK:IKPM
|
-0.005x |
|
Toppoint Holdings Inc.
NYSE MKT:TOPP
|
-0.049x |
|
Anew Medical, Inc.
NASDAQ:WENA
|
0.274x |
|
Prg Holdings Bhd
KLSE:7168
|
-0.006x |
|
Tincorp Metals Inc.
OTCQX:TINFF
|
-0.007x |
|
ZYTRONIC PLC LS-01
F:8HD
|
N/A |
Annual Cash Flow Conversion Efficiency for Quantum Genomics SA (2012–2022)
The table below shows the annual cash flow conversion efficiency of Quantum Genomics SA from 2012 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €3.61 Million | €-20.21 Million | -5.603x | -218.28% |
| 2021-12-31 | €9.67 Million | €-17.02 Million | -1.760x | -261.87% |
| 2020-12-31 | €24.65 Million | €-11.99 Million | -0.486x | +56.12% |
| 2019-12-31 | €9.41 Million | €-10.43 Million | -1.109x | -20.70% |
| 2018-12-31 | €11.87 Million | €-10.90 Million | -0.919x | -2.15% |
| 2017-12-31 | €8.87 Million | €-7.98 Million | -0.899x | -91.70% |
| 2016-12-31 | €11.79 Million | €-5.53 Million | -0.469x | -19.75% |
| 2015-12-31 | €8.02 Million | €-3.14 Million | -0.392x | -101.82% |
| 2014-12-31 | €-129.79K | €-2.79 Million | 21.503x | +3447.81% |
| 2013-12-31 | €-1.63 Million | €-987.00K | 0.606x | -9.37% |
| 2012-12-31 | €-918.08K | €-614.00K | 0.669x | -- |